California Public Employees Retirement System Akero Therapeutics, Inc. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$24.81 - $32.35 $682,275 - $889,625
-27,500 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$24.04 - $34.19 $60,797 - $86,466
-2,529 Reduced 8.42%
27,500 $798,000
Q4 2020

Feb 02, 2021
SELL
$25.12 - $29.89 $36,373 - $43,280
-1,448 Reduced 4.6%
30,029 $775,000
Q3 2020

Nov 05, 2020
BUY
$30.79 - $39.92 $208,140 - $269,859
6,760 Added 27.35%
31,477 $969,000
Q2 2020

Aug 12, 2020
BUY
$19.25 - $26.76 $475,802 - $661,426
24,717 New
24,717 $616,000

Others Institutions Holding AKRO

# of Institutions
193
Shares Held
74.6M
Call Options Held
241K
Put Options Held
647K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.6B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email